cupure logo
womencancermeaslesexpertstrumppatientscommonbrainareadoctors

Semaglutide found to have shocking benefit for liver disease patients in new study

Semaglutide found to have shocking benefit for liver disease patients in new study
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

Comments

Health news